Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma von Ngeow, J., Lim, W.T., Leong, S.S., Ang, M.K., Toh, C.K., Gao, F., Chowbay, B., Tan, E.H.

Volltext

Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients von Kho, C.Y.X., Lim, D.W.-T., Tan, D.S.W., Tan, W.L., Rajasekaran, T., Jain, A., Toh, C.K., Ang, M.-K., Tan, E.H., Ng, Q.S.

Volltext

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma von Tan, S-Y, Ooi, A-S, Ang, M-K, Koh, M, Wong, J-C, Dykema, K, Ngeow, J, Loong, S, Gatter, K, Tan, L, Lim, L-C, Furge, K, Tao, M, Lim, S-T, Loong, F, Cheah, P L, Teh, B-T

Volltext

Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Sin... von Chua, B., Tan, E.H., Lim, D.W.-T., Ang, M.-K., Tan, D.S.W., Ng, Q.-S., Kanesvaran, R., Jain, A., Tan, W.-L., Toh, C.K., Rajasekaran, T.

Volltext

Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma von Han, S., Yeong, J., Lim, C.X., Ang, M.-K., Lim, W.T.D., Toh, C.K., Ng, Q.S., Tan, D.S., Lim, T.K.H., Loh, J.H., Tanako, A., Kanesvaran, R., Tan, W.L., Rajasekaran, T., Nei, W., Jain, A.

Volltext

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma von Choo, S.P, Chowbay, B, Ng, Q.S, Thng, C.H, Lim, Cindy, Hartono, S, Koh, T.S, Huynh, H, Poon, D, Ang, M.K, Chang, S, Toh, H.C

Volltext

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers von Tan, E.-H., Goh, C., Lim, W.T., Soo, K.C., Khoo, M.L., Tan, T., Tan, D.S.W., Ang, M.K., Ng, Q.S., Tan, P.H., Lim, A., Hwang, J., Teng, Y.H.F., Lim, T.H., Tan, S.H., Baskaran, N., Hui, K.M.

Volltext

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck... von Keam, B., Machiels, J.-P., Kim, H.R., Licitra, L., Golusinski, W., Gregoire, V., Lee, Y.G., Belka, C., Guo, Y., Rajappa, S.J., Tahara, M., Azrif, M., Ang, M.K., Yang, M.-H., Wang, C.-H., Ng, Q.S., Wan Zamaniah, W.I., Kiyota, N., Babu, S., Yang, K., Curigliano, G., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G.

Volltext

Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer von Zhao, N, Ang, M-K, Yin, X-Y, Patel, M R, Fritchie, K, Thorne, L, Muldrew, K L, Hayward, M C, Sun, W, Wilkerson, M D, Chera, B S, Hackman, T, Zanation, A M, Grilley-Olson, J E, Couch, M E, Shockley, W W, Weissler, M C, Shores, C G, Funkhouser, W K, Olshan, A F, Hayes, D N

Volltext

Herbal Medicines and Perioperative Care von Ang-Lee, Michael K, Moss, Jonathan, Yuan, Chun-Su

Volltext

Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomize... von Toh, H.C., Yang, M.-H., Wang, H.-M., Hsieh, C.Y., Chitapanarux, I., Ho, K.F., Hong, R.-L., Ang, M.K., Colevas, A.D., Sirachainan, E., Lertbutsayanukul, C., Ho, G.F., Nadler, E., Algazi, A., Lulla, P., Wirth, L.J., Wirasorn, K., Liu, Y.C., Ang, S.F., Low, S.H.J., Tho, L.M., Hasbullah, H.H., Brenner, M.K., Wang, W.-W., Ong, W.S., Tan, S.H., Horak, I., Ding, C., Myo, A., Samol, J.

Volltext

Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers von Ng, C J, Teo, C H, Ang, K M, Kok, Y L, Ashraf, K, Leong, H L, Taher, S W, Mohd, Said Z, Zakaria, Z F, Wong, P F, Hor, C P, Ong, T A, Hussain, H, V, Paranthaman, Ng, C W, Agamutu, K, Abd Razak, M A

Volltext

Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers von Gutierrez, Sandra, Ang-Lee, Michael K, Walker, Diana J, Zacny, James P

Volltext

911P Post-radiotherapy (RT) Epstein-Barr virus (EBV) DNA dynamics identifies optimal timepoint for stratification of high-risk nasopharyngeal carcinoma (NPC) von Tan, J.S.H., Neo, J., Ong, E.H.W., Chow, W.M., Fong, K.W., Soong, Y.L., Sin, S.Y., Tan, D.S.W., Ang, M-K., Tan, S.H., Lim, D.W-T., Chua, M.L.K.

Volltext

422P Claudin-1 (CLDN1) expression in nasopharyngeal carcinoma (NPC): Association with immune exclusion and implications for immune checkpoint inhibitor (ICI) therapy von Yeo, E.L.L., Neo, J., Ong, E., Chow, W.M., Tan, K.M., Tan, J., Yeong, J.P.S., Lim, T.K.H., Hwang, J.S.G., Ng, Q.S., Soong, Y.L., Ang, M-K., Tan, S.H., Chua, M.L.K., Lim, D.W-T.

Volltext

405O Accuracy of plasma Epstein-Barr virus (EBV) DNA for disease surveillance in endemic nasopharyngeal carcinoma (NPC): Analysis of a real-world database (RWD) von Chow, W.M.M., Neo, J., Ong, E., Wee, J., Fong, K.W., Soong, Y.L., Tan, T., Tan, J., Sin, S.Y., Liu, J., Loh, K.S., Tay, J.K., Ang, M-K., Tan, S.H., Lim, D.W-T., Chua, M.L.K.

Volltext

674P Real-world outcomes of first-line platinum doublet chemotherapy plus Tyrosine Kinase Inhibitors (TKI) in advanced epidermal growth factor receptor (EGFR)-mutated non-small cel... von Low, Y.F., Lai, G., Seet, A., Tan, W.C., Tan, A.C., Chan, J., Teh, Y.L., Tan, W.L., Jain, A., Ng, Q.S., Ang, M-K., Kanesvaran, R., Lim, D.W-T., Tan, D.S.W., Saw, P.L.S.

Volltext

924P Claudin-1 (CLDN1) tight junction protein expression delineates distinct immune infiltrates in ascending (A) vs descending (D) subtypes of nasopharyngeal carcinoma: Potential i... von Lim, D.W-T., Yeo, E., Neo, J., Ong, E., Chow, W.M., Tan, K.M., Tan, J., Yeong, J.P.S., Lim, T.K.H., Hwang, J.S.G., Ng, Q.S., Soong, Y.L., Ang, M-K., Tan, S.H., Chua, M.L.K.

Volltext

227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse von Neo, J., Ong, E., Sim, A., Miao, J.J., Wee, J.T.S., Fong, K.W., Soong, Y.L., Sin, S.Y., Tan, D.S.W., Lim, D.W-T., Ang, M-K., Chua, M.L.K.

Volltext

EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer von Tan, W.L., Tan, S.H., Tan, D.S.W., Lai, G.G.Y., Ang, M.-K., Jain, A., Kanesvaran, R., Rajasekaran, T., Saw, S.P.L., Teh, Y.L., Chan, J., Ng, Q.S., Lim, D.W.-T.

Volltext